MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PLX made $17,851K in revenue. $2,355K in net income. Net profit margin of 13.19%.

Income Overview

Revenue
$17,851K
Net Income
$2,355K
Net Profit Margin
13.19%
EPS
$0.03
Unit: Thousand (K) dollars
Revenue Breakdown
    • Chiesi
    • Fiocruz
    • Pfizer
    • License And Service
Revenue Breakdown
    • Chiesi
    • Fiocruz
    • Pfizer
    • License And Service
Revenue Breakdown
    • Segment reporting, other segment...
    • Labor and related expense
    • Income (loss) from continuing op...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-09-30
2024-06-30
Total revenue
17,851 15,658 17,959 13,474
Cost of goods sold
8,324 5,870 8,375 9,456
Research and development expenses
4,467 5,992 2,998 2,961
Selling, general and administrative expenses
2,929 2,624 2,595 3,484
Operating income (loss)
2,131 1,172 3,991 -2,427
Financial expenses
180 783 --
Financial income
288 272 151 522
Other nonoperating expense
--299 367
Financial income (expenses), net
108 -511 -148 155
Income (loss) before taxes on income
2,239 661 3,843 -2,272
Taxes on income (tax benefit)
-116 497 607 -69
Net income (loss)
2,355 164 3,236 -2,203
Earnings per share, basic
0.03 0 0.04 -0.03
Earnings per share, diluted
0.03 0 0.03 -0.03
Weighted average number of shares outstanding, basic
79,281,685 78,663,884 73,549,745 73,308,281
Weighted average number of shares outstanding, diluted
80,814,564 81,271,610 81,217,068 73,308,281
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Chiesi$8,763K Fiocruz$6,105K Pfizer$2,805K License And Service$178K Product$17,673K Financial income$288K Total revenue$17,851K Financial income(expenses), net$108K Operating income (loss)$2,131K Financial expenses$180K Selling, general andadministrative expenses$2,929K Research and developmentexpenses$4,467K Cost of goods sold$8,324K Taxes on income (taxbenefit)-$116K Income (loss) beforetaxes on income$2,239K Net income (loss)$2,355K

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics, Inc. (PLX)